Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazuo Ohara
Institution:
Juntendo University
Observed institution:
Juntendo University
OpenAlex ID:
A5102366737
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
2021
·
Sakiko Harada
, Miki Ando
, et al.
·
Molecular Therapy
·
43
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers
2020
·
Tadahiro Honda
, Miki Ando
, et al.
·
Molecular Therapy
·
31
PDF
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
2021
·
Midori Ishii
, Jun Ando
, et al.
·
Cancer Immunology Research
·
19
SCLC-J1, a novel small cell lung cancer cell line
2021
·
Kazuo Ohara
, Shintaro Kinoshita
, et al.
·
Biochemistry and Biophysics Reports
·
4
PDF
Data from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
2023
·
Midori Ishii
, Jun Ando
, et al.
Supplementary Figure and Table from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
2023
·
Midori Ishii
, Jun Ando
, et al.
Data from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
2023
·
Midori Ishii
, Jun Ando
, et al.
Supplementary Figure and Table from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
2023
·
Midori Ishii
, Jun Ando
, et al.
Development of iPS cell derived LMP1-CART therapy for refractory EB virus associated lymphomas
2019
·
Sakiko Harada
, Miki Ando
, et al.
·
The Japanese Society of Hematology
Show more works
View as search
Works count:
9
Citation count:
97
H-index:
4
I10-index:
3
Year
Topic
Type
